School-located Influenza Vaccination Clinics for Adolescents
NCT03137667 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 17650
Last updated 2017-05-04
Summary
A cluster-randomized trial (clustering by school) was conducted in Monroe County, NY. Twenty middle and high schools were paired based on several characteristics and randomized within pairs to receiving a school-based influenza vaccination clinic or not (control).
Conditions
- Childhood Influenza Vaccination
- School-located Influenza Vaccination
Interventions
- OTHER
-
School-located Influenza Vaccination
Children in the intervention arm are enrolled in schools in Monroe County, New York that are offering school-located influenza vaccination clinics during school hours
Sponsors & Collaborators
-
University of Rochester
collaborator OTHER -
Agency for Healthcare Research and Quality (AHRQ)
collaborator FED -
University of California, Los Angeles
lead OTHER
Study Design
- Allocation
- RANDOMIZED
- Purpose
- HEALTH_SERVICES_RESEARCH
- Masking
- SINGLE
- Model
- PARALLEL
Eligibility
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2015-11-30
- Primary Completion
- 2016-01-15
- Completion
- 2016-07-31
More Related Trials
-
Administration of the Nasal Influenza Vaccine to Children in Daycare or at a Healthcare Facility
NCT07310472 ·Status: RECRUITING ·Phase: NA
-
Immunogenicity and Safety of Influenza Virus Vaccine, AdimFlu-S (A/H1N1), in Pediatric Population
NCT01007201 ·Status: COMPLETED ·Phase: NA
-
Development of Childhood Anti-Influenza Immunity
NCT03673345 ·Status: COMPLETED ·Phase: PHASE4
-
Evaluation of a Recombinant Quadrivalent Influenza Vaccine Versus a Marketed Quadrivalent Inactivated Influenza Vaccine in Children 3 to 17.
NCT03460743 ·Status: COMPLETED ·Phase: PHASE3
-
From Innovation to Solutions: Childhood Influenza Vaccination Planning
NCT01664793 ·Status: COMPLETED ·Phase: NA
-
A Clinical Trial of an Quadrivalent Inactivated Influenza Vaccine in Healthy Children Aged 6 to 35 Months
NCT05212623 ·Status: COMPLETED ·Phase: PHASE1
-
Influenza Immunity in Children
NCT02559505 ·Status: COMPLETED ·Phase: NA
-
Study of a Flu Vaccine in Children
NCT00001127 ·Status: COMPLETED ·Phase: PHASE3
-
Effect of Age and Prior Immunity on Response to H1N1 Vaccines in Children
NCT01097941 ·Status: WITHDRAWN ·Phase: PHASE4
-
Evaluation of the Effectiveness of Vaccination With 2009 H1N1 Vaccines During Influenza Season 2010-11
NCT01206114 ·Status: COMPLETED
-
Immunogenicity and Safety Evaluation of QIS in Healthy Subjects
NCT04101435 ·Status: COMPLETED ·Phase: PHASE3
-
Novel Influenza A/H1N1 Split- Virion Vaccine in Healthy Population Aged 3 Years and Older
NCT00975572 ·Status: COMPLETED ·Phase: PHASE2
-
Safety and Immunogenicity of A/H1N1-SOIV (Swine Flu) Vaccine With and Without Adjuvant in Children, Adolescents and Adults (3 to 64 Years)
NCT00973700 ·Status: COMPLETED ·Phase: PHASE3
-
Safety and Immunogenicity of a Monovalent Inactivated Influenza H3N2 Variant (H3N2v) Vaccine in Pediatric Populations
NCT02100436 ·Status: COMPLETED ·Phase: PHASE2
-
Safety and Immunogenicity of Three Commercially Available Influenza Vaccines in Children Aged 6 to <36 Months
NCT00311428 ·Status: COMPLETED ·Phase: PHASE4
-
Immunologic Response to Influenza Vaccination in Children and Adolescents
NCT03614975 ·Status: COMPLETED ·Phase: PHASE4
-
Infectivity, Replication & Immunogenicity of Live nH1N1 Vaccine
NCT01023776 ·Status: COMPLETED ·Phase: PHASE4
-
The Clinical Trial Protocol for the Influenza Virus Vaccine (Split Virion, Inactivated) (Children Forms of Drug)
NCT01551823 ·Status: COMPLETED ·Phase: PHASE3
-
To Identify the Immunogenicity and Safety of QIV in Children Aged 3-8 Years
NCT05389137 ·Status: UNKNOWN ·Phase: PHASE4
-
Safety and Immunogenicity of A/H1N1-SOIV (Swine Flu) Vaccine With and Without Adjuvant in Children (3 to < 9 Years)
NCT00972816 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
Safety and Immunogenicity of Two Doses of H5N1 Influenza Vaccine in Children
NCT01776554 ·Status: COMPLETED ·Phase: PHASE2
-
Does Seasonal Influenza Vaccination Affect the Incidence of pH1N1 Influenza?
NCT01001325 ·Status: COMPLETED ·Phase: PHASE3
-
A Study of Inactivated Swine-Origin A/H1N1 Influenza Vaccines in Healthy European Subjects Aged 3 to 17 Years
NCT00956202 ·Status: COMPLETED ·Phase: PHASE2
-
Immunologic Response to Inactivated Vaccine for Novel H1N1 Virus
NCT01023711 ·Status: COMPLETED ·Phase: NA
-
Safety and Immunogenicity Study of a H5N1 Influenza Vaccine (Vero Cell-Derived, Whole Virus) in Healthy Infants, Children and Adolescents
NCT01052402 ·Status: COMPLETED ·Phase: PHASE1/PHASE2